FENC logo

Fennec Pharmaceuticals (FENC) Working Capital

Annual Working Capital

$19.30 M
-$2.81 M-12.72%

December 31, 2023


Summary


Performance

FENC Working Capital Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherFENCbalance sheetmetrics:

Quarterly Working Capital

$50.53 M
-$3.89 M-7.15%

September 30, 2024


Summary


Performance

FENC Quarterly Working Capital Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherFENCbalance sheetmetrics:

Working Capital Formula

Working Capital = Current Assets − Current Liabilities

FENC Working Capital Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-12.7%-7.2%
3 y3 years-33.6%+186.4%
5 y5 years-9.4%+186.4%

FENC Working Capital Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-12.7%at low-13.4%+303.7%
5 y5-year-33.6%+66.2%-13.4%+515.0%
alltimeall time-33.6%+489.4%-13.4%+657.4%

Fennec Pharmaceuticals Working Capital History

DateAnnualQuarterly
Sep 2024
-
$50.53 M(-7.2%)
Jun 2024
-
$54.42 M(-6.7%)
Mar 2024
-
$58.34 M(+202.2%)
Dec 2023
$19.30 M(-12.7%)
$19.30 M(+28.4%)
Sep 2023
-
$15.03 M(-3.3%)
Jun 2023
-
$15.55 M(-11.8%)
Mar 2023
-
$17.64 M(-20.2%)
Dec 2022
$22.12 M(+6.7%)
$22.12 M(-18.8%)
Sep 2022
-
$27.23 M(+117.5%)
Jun 2022
-
$12.52 M(-26.3%)
Mar 2022
-
$16.99 M(-18.0%)
Dec 2021
$20.73 M(-28.7%)
$20.73 M(-13.5%)
Sep 2021
-
$23.96 M(-12.0%)
Jun 2021
-
$27.23 M(+9.2%)
Mar 2021
-
$24.93 M(-14.2%)
Dec 2020
$29.07 M(+150.3%)
$29.07 M(-6.8%)
Sep 2020
-
$31.18 M(-12.7%)
Jun 2020
-
$35.71 M(+334.6%)
Mar 2020
-
$8.22 M(-29.3%)
Dec 2019
$11.61 M(-45.5%)
$11.61 M(-21.1%)
Sep 2019
-
$14.72 M(-9.0%)
Jun 2019
-
$16.18 M(-14.4%)
Mar 2019
-
$18.89 M(-11.4%)
Dec 2018
$21.31 M(-20.3%)
$21.31 M(-6.8%)
Sep 2018
-
$22.86 M(-8.0%)
Jun 2018
-
$24.86 M(-3.1%)
Mar 2018
-
$25.66 M(-4.1%)
Dec 2017
$26.76 M(+649.5%)
$26.76 M(+202.1%)
Sep 2017
-
$8.86 M(-8.5%)
Jun 2017
-
$9.68 M(+238.3%)
Mar 2017
-
$2.86 M(-19.9%)
Dec 2016
$3.57 M(+551.5%)
$3.57 M(-15.4%)
Sep 2016
-
$4.22 M(-9.3%)
Jun 2016
-
$4.65 M(+1814.8%)
Mar 2016
-
$243.00 K(-55.7%)
Dec 2015
$548.00 K(-10.6%)
$548.00 K(-46.2%)
Sep 2015
-
$1.02 M(-8.4%)
Jun 2015
-
$1.11 M(+34.6%)
Mar 2015
-
$826.00 K(+34.7%)
Dec 2014
$613.00 K(-142.1%)
$613.00 K(-119.0%)
Sep 2014
-
-$3.23 M(-30.7%)
Jun 2014
-
-$4.66 M(+7.5%)
Mar 2014
-
-$4.33 M(+197.9%)
Dec 2013
-$1.46 M(-70.6%)
-$1.46 M(-64.7%)
Sep 2013
-
-$4.13 M(+69.9%)
Jun 2013
-
-$2.43 M(-73.2%)
Mar 2013
-
-$9.06 M(+82.9%)
DateAnnualQuarterly
Dec 2012
-$4.96 M(+4030.8%)
-$4.96 M(-486.1%)
Sep 2012
-
$1.28 M(-37.2%)
Jun 2012
-
$2.04 M(-21.2%)
Mar 2012
-
$2.60 M(-2262.5%)
Dec 2011
-$120.00 K(-97.6%)
-$120.00 K(-96.7%)
Sep 2011
-
-$3.67 M(+436.5%)
Jun 2011
-
-$684.00 K(+140.0%)
Mar 2011
-
-$285.00 K(-94.2%)
Dec 2010
-$4.92 M(-1292.3%)
-$4.92 M(-178.2%)
Sep 2010
-
$6.30 M(-7.2%)
Jun 2010
-
$6.79 M(>+9900.0%)
Mar 2010
-
$47.00 K(-88.6%)
Dec 2009
$413.00 K(-87.1%)
$413.00 K(-30.0%)
Sep 2009
-
$590.00 K(-38.2%)
Jun 2009
-
$954.00 K(-42.3%)
Mar 2009
-
$1.65 M(-48.5%)
Dec 2008
$3.21 M(-77.3%)
$3.21 M(-39.4%)
Sep 2008
-
$5.30 M(-36.2%)
Jun 2008
-
$8.30 M(-26.2%)
Mar 2008
-
$11.25 M(-20.6%)
Dec 2007
$14.16 M(+1079.9%)
$14.16 M(-15.1%)
Sep 2007
-
$16.68 M(-14.4%)
Jun 2007
-
$19.48 M(-5.8%)
Mar 2007
-
$20.69 M(+1624.1%)
Dec 2006
$1.20 M(-88.8%)
$1.20 M(-79.1%)
Sep 2006
-
$5.74 M(-43.6%)
Jun 2006
-
$10.17 M(+30.7%)
Mar 2006
-
$7.78 M(-27.5%)
Dec 2005
$10.73 M(-46.9%)
$10.73 M(-27.5%)
Sep 2005
-
$14.81 M(+45.6%)
Jun 2005
-
$10.17 M(-24.9%)
Mar 2005
-
$13.54 M(-29.4%)
Sep 2004
-
$19.18 M(-5.1%)
Jun 2004
$20.20 M(+799.8%)
$20.20 M(+44.6%)
Mar 2004
-
$13.97 M(-14.6%)
Dec 2003
-
$16.36 M(+1242.3%)
Sep 2003
-
$1.22 M(-45.7%)
Jun 2003
$2.25 M(-59.1%)
$2.25 M(+104.8%)
Mar 2003
-
$1.10 M(-51.5%)
Dec 2002
-
$2.26 M(-44.0%)
Sep 2002
-
$4.04 M(-26.5%)
Jun 2002
$5.49 M(-41.6%)
$5.49 M(-15.6%)
Mar 2002
-
$6.51 M(-12.7%)
Dec 2001
-
$7.45 M(-8.3%)
Sep 2001
-
$8.13 M(-13.6%)
Jun 2001
$9.41 M(<-9900.0%)
$9.41 M(+79.5%)
Dec 2000
-
$5.24 M
Jun 2000
-$43.60 K
-

FAQ

  • What is Fennec Pharmaceuticals annual working capital?
  • What is the all time high annual working capital for Fennec Pharmaceuticals?
  • What is Fennec Pharmaceuticals annual working capital year-on-year change?
  • What is Fennec Pharmaceuticals quarterly working capital?
  • What is the all time high quarterly working capital for Fennec Pharmaceuticals?
  • What is Fennec Pharmaceuticals quarterly working capital year-on-year change?

What is Fennec Pharmaceuticals annual working capital?

The current annual working capital of FENC is $19.30 M

What is the all time high annual working capital for Fennec Pharmaceuticals?

Fennec Pharmaceuticals all-time high annual working capital is $29.07 M

What is Fennec Pharmaceuticals annual working capital year-on-year change?

Over the past year, FENC annual working capital has changed by -$2.81 M (-12.72%)

What is Fennec Pharmaceuticals quarterly working capital?

The current quarterly working capital of FENC is $50.53 M

What is the all time high quarterly working capital for Fennec Pharmaceuticals?

Fennec Pharmaceuticals all-time high quarterly working capital is $58.34 M

What is Fennec Pharmaceuticals quarterly working capital year-on-year change?

Over the past year, FENC quarterly working capital has changed by -$3.89 M (-7.15%)